Feline leukemia virus infection

Canine and Feline Infectious Diseases

Volumn , Issue , 2013, Pages 224-238

  Sykes, Jane E ^a   Hartmann, Katrin ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903922378     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0795-3.00022-3     Document Type: Chapter

References (101)

1. W.F.H. Jarrett., E.M. Crawford., W.B. Martin., et al. A virus-like particle associated with leukemia (lymphosarcoma) Nature 202 1964 567-569.
2. M.L. Meli., V. Cattori., F. Martinez., et al. Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus) PLoS One 4 2009 e4744.
3. M.A. Stewart., M. Warnock., A. Wheeler., et al. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses J Virol 58 1986 825-834.
4. A.S. Lauring., M.M. Anderson., J. Overbaugh Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants J Virol 75 2001 8888-8898.
5. J. Brojatsch., B.S. Kristal., G.A. Viglianti., et al. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein Proc Natl Acad Sci U S A 89 1992 8457-8461.
6. C. Chandhasin., P.N. Coan., L.S. Levy Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum J Virol 79 2005 1351-1360.
7. C. Chandhasin., P.N. Coan., I. Pandrea., et al. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome J Virol 79 2005 5278-5287.
8. M. Vobis., J. D’Haese., H. Mehlhorn., et al. Evidence of horizontal transmission of feline leukemia virus by the cat flea (Ctenocephalides felis) Parasitol Res 91 2003 467-470.
9. M.A. Gomes-Keller., E. Gonczi., B. Grenacher., et al. Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential Vet Microbiol 134 2009 208-217.
10. A.M. Pacitti., O. Jarrett., D. Hay Transmission of feline leukaemia virus in the milk of a non-viraemic cat Vet Rec 118 1986 381-384.
11. A.P. Tenorio., C.E. Franti., B.R. Madewell., et al. Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses Vet Immunol Immunopathol 29 1991 1-14.
12. T.P. O’Connor, Jr., Q.J. Tonelli., J.M. Scarlett Report of the National FeLV/FIV Awareness Project J Am Vet Med Assoc 199 1991 1348-1353.
13. J.K. Levy., H.M. Scott., J.L. Lachtara., et al. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity J Am Vet Med Assoc 228 2006 371-376.
14. B. Stutzer., K. Simon., H. Lutz., et al. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma J Feline Med Surg 13 2011 81-87.
15. S.E. Gleich., S. Krieger., K. Hartmann Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany J Feline Med Surg 11 2009 985-992.
16. M. Ravi., G.A. Wobeser., S.M. Taylor., et al. Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis Can Vet J 51 2010 271-276.
17. S. Little., W. Sears., J. Lachtara., et al. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in Canada Can Vet J 50 2009 644-648.
18. E. Hellard., D. Fouchet., H. Santin-Janin., et al. When cats’ ways of life interact with their viruses: a study in 15 natural populations of owned and unowned cats (Felis silvestris catus) Prev Vet Med 101 2011 250-264.
19. Y.M. Al-Kappany., M.R. Lappin., O.C. Kwok., et al. Seroprevalence of Toxoplasma gondii and concurrent Bartonella spp., feline immunodeficiency virus, feline leukemia virus, and Dirofilaria immitis infections in Egyptian cats J Parasitol 97 2011 256-258.
20. M.J. Hosie., C. Robertson., O. Jarrett Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom Vet Rec 125 1989 293-297.
21. C.K. Grant., M. Essex., M.B. Gardner., et al. Natural feline leukemia virus infection and the immune response of cats of different ages Cancer Res 40 1980 823-829.
22. R. Hofmann-Lehmann., R. Tandon., F.S. Boretti., et al. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays Vaccine 24 2006 1087-1094.
23. E. Kadar., J.E. Sykes., P.H. Kass., et al. Evaluation of the prevalence of infections in cats after renal transplantation: 169 cases (1987-2003) J Am Vet Med Assoc 227 2005 948-953.
24. A. Major., V. Cattori., E. Boenzli., et al. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection Vet Res 41 2010 17.
25. R.A. Good., M. Ogasawara., W.T. Liu., et al. Immunosuppressive actions of retroviruses Lymphology 23 1990 56-59.
26. G.J. Cianciolo., T.D. Copeland., S. Oroszlan., et al. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins Science 230 1985 453-455.
27. M. Mitani., G.J. Cianciolo., R. Snyderman., et al. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses Proc Natl Acad Sci U S A 84 1987 237-240.
28. S. Haraguchi., R.A. Good., N.K. Day-Good A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways Immunol Res 41 2008 46-55.
29. G.L. Cockerell., E.A. Hoover., S. Krakowka., et al. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat J Natl Cancer Inst 57 1976 1095-1099.
30. L.C. Hebebrand., L.E. Mathes., R.G. Olsen Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus Cancer Res 37 1977 4532-4533.
31. L.E. Mathes., R.G. Olsen., L.C. Hebebrand., et al. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein Nature 274 1978 687-689.
32. L.E. Perryman., E.A. Hoover., D.S. Yohn Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia J Natl Cancer Inst 49 1972 1357-1365.
33. Z. Trainin., D. Wernicke., H. Ungar-Waron., et al. Suppression of the humoral antibody response in natural retrovirus infections Science 220 1983 858-859.
34. D. Wernicke., Z. Trainin., H. Ungar-Waron., et al. Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus J Virol 60 1986 669-673.
35. L.J. Lafrado., R.G. Olsen Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FeLV-infected cats Cancer Invest 4 1986 297-300.
36. M. Hoffmann-Jagielska., A. Winnicka., D. Jagielski., et al. Influence of naturally acquired feline leukemia virus (FeLV) infection on the phagocytic and respiratory burst activity of neutrophils and monocytes of peripheral blood Pol J Vet Sci 8 2005 93-97.
37. A.B. Wardini., A.B. Guimaraes-Costa., M.T. Nascimento., et al. Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus J Gen Virol 91 2010 259-264.
38. A.U. Buchmann., O. Kershaw., V.A. Kempf., et al. Does a feline leukemia virus infection pave the way for Bartonella henselae infection in cats? J Clin Microbiol 48 2010 3295-3300.
39. Y. Fujino., K. Ohno., H. Tsujimoto Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis Vet Immunol Immunopathol 123 2008 138-143.
40. G.H. Shelton., C.K. Grant., S.M. Cotter., et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988) J Acquir Immune Defic Syndr 3 1990 623-630.
41. M. Reinacher Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats Vet Immunol Immunopathol 21 1989 85-95.
42. M. Louwerens., C.A. London., N.C. Pedersen., et al. Feline lymphoma in the post-feline leukemia virus era J Vet Intern Med 19 2005 329-335.
43. E. Teske., G. van Straten., R. van Noort., et al. Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol J Vet Intern Med 16 2002 179-186.
44. S.S. Taylor., M.R. Goodfellow., W.J. Browne., et al. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats J Small Anim Pract 50 2009 584-592.
45. E.L. Krick., L. Little., R. Patel., et al. Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004) Vet Comp Oncol 6 2008 102-110.
46. D.P. Francis., M. Essex., S.M. Cotter., et al. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus Cancer Lett 12 1981 37-42.
47. J. Wang., M. Kyaw-Tanner., C. Lee., et al. Characterisation of lymphosarcomas in Australian cats using polymerase chain reaction and immunohistochemical examination Aust Vet J 79 2001 41-46.
48. J.A. Beatty., S. Tasker., O. Jarrett., et al. Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence J Feline Med Surg 13 2011 927-933.
49. M.L. Jackson., D.M. Haines., S.M. Meric., et al. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma Can J Vet Res 57 1993 269-276.
50. L.J. Gabor., M.L. Jackson., B. Trask., et al. Feline leukaemia virus status of Australian cats with lymphosarcoma Aust Vet J 79 2001 476-481.
51. M.E. Gelain., E. Antoniazzi., W. Bertazzolo., et al. Chronic eosinophilic leukemia in a cat: cytochemical and immunophenotypical features Vet Clin Pathol 35 2006 454-459.
52. T. Shimoda., N. Shiranaga., T. Mashita., et al. Chronic myelomonocytic leukemia in a cat J Vet Med Sci 62 2000 195-197.
53. P. Besmer., E. Lader., P.C. George., et al. A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein J Virol 60 1986 194-203.
54. L. Donner., L.A. Fedele., C.F. Garon., et al. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms) J Virol 41 1982 489-500.
55. J. Stiles., D. Bienzle., J.A. Render., et al. Use of nested polymerase chain reaction (PCR) for detection of retroviruses from formalin-fixed, paraffin-embedded uveal melanomas in cats Vet Ophthalmol 2 1999 113-116.
56. C.L. Cullen., D.M. Haines., M.L. Jackson., et al. The use of immunohistochemistry and the polymerase chain reaction for detection of feline leukemia virus and feline sarcoma virus in six cases of feline ocular sarcoma Vet Ophthalmol 1 1998 189-193.
57. C.L. Cullen., D.M. Haines., M.L. Jackson., et al. Lack of detection of feline leukemia and feline sarcoma viruses in diffuse iris melanomas of cats by immunohistochemistry and polymerase chain reaction J Vet Diagn Invest 14 2002 340-343.
58. J.A. Ellis., M.L. Jackson., R.C. Bartsch., et al. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats J Am Vet Med Assoc 209 1996 767-771.
59. B.A. Kidney., J.A. Ellis., D.M. Haines., et al. Comparison of endogenous feline leukemia virus RNA content in feline vaccine and nonvaccine site-associated sarcomas Am J Vet Res 62 2001 1990-1994.
60. K. Hartmann Clinical aspects of feline immunodeficiency and feline leukemia virus infection Vet Immunol Immunopathol 143 2011 190-201.
61. G.H. Shelton., M.L. Linenberger Hematologic abnormalities associated with retroviral infections in the cat Semin Vet Med Surg (Small Anim) 10 1995 220-233.
62. J.G. Quigley., Z. Yang., M.T. Worthington., et al. Identification of a human heme exporter that is essential for erythropoiesis Cell 118 2004 757-766.
63. M. Hisasue., H. Okayama., T. Okayama., et al. Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes J Vet Intern Med 15 2001 471-477.
64. D.J. Weiss Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005) J Am Vet Med Assoc 228 2006 893-897.
65. B. Stutzer., F. Muller., M. Majzoub., et al. Role of latent feline leukemia virus infection in nonregenerative cytopenias of cats J Vet Intern Med 24 2010 192-197.
66. L.J. Anderson., W.F. Jarrett Membranous glomerulonephritis associated with leukaemia in cats Res Vet Sci 12 1971 179-180.
67. A.H. Brightman, 2nd., G.K. Ogilvie., M. Tompkins Ocular disease in FeLV-positive cats: 11 cases (1981-1986) J Am Vet Med Assoc 198 1991 1049-1051.
68. N.C. Pedersen., R.R. Pool., T. O’Brien Feline chronic progressive polyarthritis Am J Vet Res 41 1980 522-535.
69. D.L. Tuomari., R.G. Olsen., V.K. Singh., et al. Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection Vet Immunol Immunopathol 7 1984 227-238.
70. N.K. Day., C. O’Reilly-Felice., W.D. Hardy, Jr., et al. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats J Immunol 125 1980 2363-2366.
71. H.W. Snyder, Jr., F.R. Jones., N.K. Day., et al. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption J Immunol 128 1982 2726-2730.
72. A.D. Fails., T.W. Mitchell., J.L. Rojko., et al. An oligopeptide of the feline leukemia virus envelope glycoprotein is associated with morphological changes and calcium dysregulation in neuronal growth cones J Neurovirol 3 1997 179-191.
73. T.W. Mitchell., J.L. Rojko., J.R. Hartke., et al. FeLV envelope protein (gp70) variable region 5 causes alterations in calcium homeostasis and toxicity of neurons J Acquir Immune Defic Syndr Hum Retrovirol 14 1997 307-320.
74. K.P. Carmichael., D. Bienzle., J.J. McDonnell Feline leukemia virus-associated myelopathy in cats Vet Pathol 39 2002 536-545.
75. A. Kipar., J. Kremendahl., M.L. Jackson., et al. Comparative examination of cats with feline leukemia virus-associated enteritis and other relevant forms of feline enteritis Vet Pathol 38 2001 359-371.
76. W.D. Hardy, Jr., P.W. Hess., E.G. MacEwen., et al. Biology of feline leukemia virus in the natural environment Cancer Res 36 1976 582-588.
77. H. Lutz., I. Castelli., F. Ehrensperger., et al. Panleukopenia-like syndrome of FeLV caused by co-infection with FeLV and feline panleukopenia virus Vet Immunol Immunopathol 46 1995 21-33.
78. A. Kipar., J. Kremendahl., D.D. Addie., et al. Fatal enteritis associated with coronavirus infection in cats J Comp Pathol 119 1998 1-14.
79. J. Levy., C. Crawford., K. Hartmann., et al. 2008 American Association of Feline Practitioners’ feline retrovirus management guidelines J Feline Med Surg 10 2008 300-316.
80. S. Gleich., K. Hartmann Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats J Vet Intern Med 23 2009 552-558.
81. K. Hartmann., P. Griessmayr., B. Schulz., et al. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection J Feline Med Surg 9 2007 439-445.
82. M.C. Barr., M.B. Pough., R.H. Jacobson., et al. Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection J Am Vet Med Assoc 199 1991 1377-1381.
83. K. Floyd., P.F. Suter., H. Lutz Granules of blood eosinophils are stained directly by anti-immunoglobulin fluorescein isothiocyanate conjugates Am J Vet Res 44 1983 2060-2063.
84. V. Cattori., R. Tandon., B. Riond., et al. The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome Vet Microbiol 133 2009 292-296.
85. M.A. Gomes-Keller., E. Gonczi., R. Tandon., et al. Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods J Clin Microbiol 44 2006 916-922.
86. R. Hofmann-Lehmann., J.B. Huder., S. Gruber., et al. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats J Gen Virol 82 2001 1589-1596.
87. A.C. Pepin., R. Tandon., V. Cattori., et al. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats Virus Res 127 2007 9-16.
88. D.A. Harbour., D.A. Gunn-Moore., T.J. Gruffydd-Jones., et al. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine Vaccine 20 2002 2866-2872.
89. A.N. Torres., K.P. O’Halloran., L.J. Larson., et al. Feline leukemia virus immunity induced by whole inactivated virus vaccination Vet Immunol Immunopathol 134 2010 122-131.
90. M. Reinacher Feline leukemia virus-associated enteritis-a condition with features of feline panleukopenia Vet Pathol 24 1987 1-4.
91. K. de Mari., L. Maynard., A. Sanquer., et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats J Vet Intern Med 18 2004 477-482.
92. K. Hartmann., A. Donath., B. Beer., et al. Use of two virustatics (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms Vet Immunol Immunopathol 35 1992 167-175.
93. P. Nelson., R. Sellon., C. Novotney., et al. Therapeutic effects of diethylcarbamazine and 3′-azido-3′-deoxythymidine on feline leukemia virus lymphoma formation Vet Immunol Immunopathol 46 1995 181-194.
94. V. Cattori., B. Weibel., H. Lutz Inhibition of feline leukemia virus replication by the integrase inhibitor raltegravir Vet Microbiol 152 2011 165-168.
95. D.D. Addie., J.M. Dennis., S. Toth., et al. Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus Vet Rec 146 2000 419-424.
96. D.M. Vail., A.S. Moore., G.K. Ogilvie., et al. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats J Vet Intern Med 12 1998 349-354.
97. Sykes JE, et al, unpublished observations. 2012.
98. R. Hofmann-Lehmann., V. Cattori., R. Tandon., et al. Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up Vaccine 25 2007 5531-5539.
99. F. Jirjis., T. Davis., J. Lane., et al. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine Vet Ther 11 2010 E1-E6.
100. J.R. Richards., T.H. Elston., R.B. Ford., et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report J Am Vet Med Assoc 229 2006 1405-1441.
101. H. Lutz., D. Addie., S. Belak., et al. Feline leukaemia. ABCD guidelines on prevention and management J Feline Med Surg 11 2009 565-574.